Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Stabilisation Notice

13 Jul 2023 11:59

RNS Number : 9601F
Mizuho International plc
13 July 2023
 

13/07/2023

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

WEIR Group Plc/The

 

Stabilisation Notice

Mizuho International plc (contact: Syndicate Desk - Maximilian Wegener; telephone: +4969427293155) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

WEIR Group Plc/The

Guarantor (if any):

Aggregate nominal amount:

GBP 300m WEIRLN 6 ⅞ 06/14/28

Description:

Senior, Unsecured, RegS Bearer Notes due in 2028

Offer price:

99.753

Other offer terms:

Stabilisation: Not carried out

Stabilising Manager(s):

Mizuho International plc (Stabilisation Coordinator)

Citigroup Global Markets Ltd

JP Morgan SE

HSBC

 

Stabilisation period expected to start on:

7th of June 2023

Stabilisation period expected to end no later than:

13th July 2023 (30 days after the proposed issue date of the securities)

Maximum size of over-allotment facility:

[5% of the aggregate nominal amount stated above.]

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is only directed at, and the securities are only available to, persons having professional experience in matters related to investments and high net worth companies and other persons to whom article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 applies and should not be acted on by others.

To the extent that the offer of the securities is made in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the date of publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or, where appropriate, published in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), the offer is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive or has been or will be made otherwise in circumstances that do not require the Issuer to publish a prospectus pursuant to the Prospectus Directive.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STARJMMTMTABBJJ
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.